Córdoba R, López-Corral L, Presa M, Martín-Escudero V, Vadgama S, Casado MÁ, Pardo C
The Health Impacts of Better Access to Axicabtagene Ciloleucel: The Case of Spain
Cancers. https://doi.org/10.3390/cancers16152712
García-Sancho AM, Presa M, Pardo C, Martín-Escudero V, Oyagüez I, Ortiz-Maldonado V
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Standard of Care in Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain
Cancers 2024, 16, 2301
Bastos-Oreiro M, de las Heras A, Presa M, Casado MA, Pardo C, Martín-Escudero V, Sureda A